Ian Gilham is Chair of LifeArc Board of Trustees and Chair of the Nominations and Board Financial Approvals Committees. Ian is an experienced leader with an international track record in the research, development and commercialisation of diagnostic and pharmaceutical products. He has proven success as a leader in mergers and acquisitions and has strong fund manager, investor relations and advisor networks in the City of London and globally. Ian is currently non-executive chair of Genedrive plc, RevoNa Bio and Pelago BioScience. He previously held various global management roles at Celltech, Amersham International, Abbott Laboratories and GSK and was CEO of Axis-Shield plc, leading to its successful sale to Alere. Subsequently, he became Executive Chair at Horizon Discovery, leading the sale of the company to Perkin-Elmer.
Dr Ian Gilham
Latest news
-
LifeArc and the Gates Foundation launches groundbreaking new projects to lower the cost of monoclonal antibody production
-
We must confront this silent pandemic as a global collective
-
PACE announces £6 million funding for antibacterial treatment innovations to fill critical gap in R&D pipeline